MedPath

IMITREX

SUMATRIPTAN

Approved
Approval ID

34b663e0-e40c-366f-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2016

Manufacturers
FDA

DIRECT RX

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SUMATRIPTAN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-408
Application NumberANDA078327
Product Classification
M
Marketing Category
C73584
G
Generic Name
SUMATRIPTAN
Product Specifications
Route of AdministrationORAL
Effective DateJune 7, 2016
FDA Product Classification

INGREDIENTS (7)

SUMATRIPTAN SUCCINATEActive
Quantity: 50 mg in 1 1
Code: J8BDZ68989
Classification: ACTIM
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92J
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IMITREX - FDA Drug Approval Details